Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-056182

President & CEO sold 19,877 shares at $0.49 ($9,740)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2023-11-17 Sale −19,877 $0.49 $9,740 899,922 D: show line 1 in the form
Open-market sales · 19,877 sh · avg $0.49 · $9,740
Loading xslF345X05/doc4.xml…